title: Current and future recombinant viral vaccines for poultry.
abstract: The use of biotechnology to create recombinant viral vaccines holds many promises for the future. But, to be practical, new vaccines must have a selective advantage over traditional vaccines. A vaccine that is novel because it is a recombinant vaccine is not enough. Recombinant vaccines must be safer, or more efficacious, or less expensive to produce in order for them to gain a niche in the marketplace.
authors.affiliation: Department of Avian Medicine, College of Veterinary Medicine, University of Georgia, Athens 30602, USA.
authors.forename: M W
authors.initials: MW
authors.lastname: Jackwood
mesh_terms: D000818:Animals; D001709:Biotechnology / Q000379:methods / Q000639:trends; D002645:Chickens; D005586:Fowlpox / Q000276:immunology / Q000517:prevention & control; D005587:Fowlpox virus; D006566:Herpesviridae Infections / Q000276:immunology / Q000517:prevention & control / Q000662:veterinary; D011201:Poultry Diseases / Q000276:immunology* / Q000517:prevention & control; D014422:Turkeys; D014611:Vaccination / Q000379:methods / Q000639:trends / Q000662:veterinary; D014614:Vaccines, Synthetic; D014765:Viral Vaccines
chemical_list: D014614:Vaccines, Synthetic; D014765:Viral Vaccines